as on October 27, 2025 at 10:31 pm IST
Day's Low
Day's High
1.79%
Downside
3.57%
Upside
52 Week's Low
52 Week's High
79.73%
Downside
598.20%
Upside
Check Klotho Neurosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$39.6M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-249.56%
Compare market cap, revenue, PE, and other key metrics of Klotho Neurosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $39.6M | NA | NA | 0.00% | |
| BUY | $60.7B | 265.42% | -505.15 | -12.96% | |
| NA | $35.8B | NA | NA | -3.89% | |
| BUY | $108.0B | 98.59% | 29.95 | 31.86% | |
| BUY | $61.3B | -0.78% | 14.55 | 31.37% |
The Klotho Neurosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Klotho Neurosciences Inc investment value today
Current value as on today
₹1,21,741
Returns
₹21,741
(+21.74%)
Returns from Klotho Neurosciences Inc Stock
₹16,667 (+16.67%)
Dollar Returns*
₹5,074 (+5.07%)
Search interest for Klotho Neurosciences Inc Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:4% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, KLTO stock has moved up by 23.7%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 138.9% return, outperforming this stock by 233.2%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.7% return, outperforming this stock by 45.5%
| Organisation | Klotho Neurosciences Inc |
| Headquarters | 13576 Walnut Street, Omaha, NE, United States, 68144 |
| CEO | Dr. Joseph Sinkule Pharm.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Joseph Sinkule Pharm.D. | Founder, CEO, Chairman of the Board & Secretary |
Mr. Jeffrey LeBlanc | Chief Financial Officer |
Dr. Shalom Z. Hirschman M.D. | Medical Advisor & Director |
Mr. Peter J. Moriarty | Chief Business Officer |
Dr. Miguel Chillon Rodriguez | Chief Scientific Officer & Consultant |
Klotho Neurosciences Inc share price today is $0.56 as on . Klotho Neurosciences Inc share today touched a day high of $0.58 and a low of $0.55.
Klotho Neurosciences Inc share touched a 52 week high of $3.91 on and a 52 week low of $0.11 on . Klotho Neurosciences Inc stock price today i.e. is trending at $0.56,which is 85.68% down from its 52 week high and 393.39% up from its 52 week low.
Klotho Neurosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Klotho Neurosciences Inc (KLTO) shares with as little as ₹88.189 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.89 in Klotho Neurosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Klotho Neurosciences Inc share’s latest price of $0.56 as on October 27, 2025 at 10:31 pm IST, you will get 17.8571 shares of Klotho Neurosciences Inc. Learn more about
fractional shares .